Global Cord Blood Corp Share Price Nyse
Equities
KYG211071009
Healthcare Facilities & Services
Sales 2021 | 1.16B 161M 12.8B | Sales 2022 | 1.24B 172M 13.73B | Capitalization | 2.97B 411M 32.76B |
---|---|---|---|---|---|
Net income 2021 | 508M 70.39M 5.61B | Net income 2022 | 501M 69.42M 5.53B | EV / Sales 2021 | -2.13 x |
Net cash position 2021 | 6.07B 842M 67.06B | Net cash position 2022 | 6.66B 923M 73.53B | EV / Sales 2022 | -2.97 x |
P/E ratio 2021 |
7.1
x | P/E ratio 2022 |
5.93
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 38.41% |
Managers | Title | Age | Since |
---|---|---|---|
Ting Zheng
CEO | Chief Executive Officer | 52 | 31/12/08 |
Bing Chuen Chen
DFI | Director of Finance/CFO | 48 | 31/12/08 |
Xin Xu
CTO | Chief Tech/Sci/R&D Officer | 70 | 31/10/04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jennifer J. Weng
BRD | Director/Board Member | 56 | 31/12/08 |
Ting Zheng
CEO | Chief Executive Officer | 52 | 31/12/08 |
Director/Board Member | 56 | 31/12/08 |
1st Jan change | Capi. | |
---|---|---|
+14.55% | 81.21B | |
-29.12% | 70.26B | |
+11.76% | 29.62B | |
-11.55% | 16.95B | |
-0.71% | 16.91B | |
-1.62% | 15.07B | |
+4.35% | 12.52B | |
-30.88% | 11.92B | |
-5.39% | 12.1B |